The REPRESSIT consortium is arranging a symposium at Karolinska Institute in Stockholm on the 16th of June 2026 with the title:
REPRESSIT or NOT:
What is the future of immune checkpoint inhibitors?
This symposium has the purpose of bringing together scientists with unique expertise, including immunology, protein design and therapeutic development to share their knowledge and experiences. The symposium will include speakers in cancer biology, immunology, protein design and biological imaging to share their work and provide a platform for open discussion.
Introduction
09:00-9:10 Introductory remarks and project introduction
Microscopy and imaging innovation
09:10-10:35
10:35-11:05 Coffee
Immune synapse and signaling
11:05-12:30
12:30-13:30 Lunch
RIPR, engager and checkpoint design
13:30-14:55
14:55-15:25 Coffee
T and NK cell engineering / Clinical translation of ICI, CAR-T and other immunotherapies
15:25-16:50
Conclusion
16:50-17:00
If you are interested and would like to join, use this from to register or scan the QR code below!
Location: Jacob Berzelius, Karolinska Institute campus Solna, Berzelius väg 3